Holen Sie sich die Stockscreener-App
8.12
5.47%
-0.47
Handel nachbörslich:
8.14
0.02
+0.25%
Schlusskurs vom Vortag:
$8.59
Offen:
$8.52
24-Stunden-Volumen:
234.76K
Relative Volume:
1.81
Marktkapitalisierung:
$411.26M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-25.50M
KGV:
-10.55
EPS:
-0.77
Netto-Cashflow:
$-30.10M
1W Leistung:
+7.27%
1M Leistung:
+36.01%
6M Leistung:
+48.72%
1J Leistung:
+168.00%
1-Tages-Spanne:
$7.96
$8.74
1-Wochen-Bereich:
$7.10
$8.74
52-Wochen-Spanne:
$2.6801
$8.74
Eupraxia Pharmaceuticals Inc Stock (EPRX) Company Profile
Firmenname
Eupraxia Pharmaceuticals Inc
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie EPRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EPRX
Eupraxia Pharmaceuticals Inc
|
8.12 | 435.07M | 0 | -25.50M | -30.10M | -0.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Eupraxia Pharmaceuticals Inc Stock (EPRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-24 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-06-26 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-06-16 | Eingeleitet | Canaccord Genuity | Speculative Buy |
| 2025-02-21 | Eingeleitet | Craig Hallum | Buy |
| 2024-11-14 | Eingeleitet | Rodman & Renshaw | Buy |
Eupraxia Pharmaceuticals Inc Aktie (EPRX) Neueste Nachrichten
(EPRX) Trading Strategy and Analysis (EPRX:CA) - Stock Traders Daily
Can Eupraxia Pharmaceuticals Inc. stock sustain institutional interest2025 Key Highlights & Expert Verified Movement Alerts - ulpravda.ru
Eupraxia Pharmaceuticals’ (EPRX) Buy Rating Reaffirmed at HC Wainwright - Defense World
Eupraxia Pharmaceuticals Inc. (TSE:EPRX) surges 15%; retail investors who own 41% shares profited along with institutions - simplywall.st
Eupraxia Trial Data Shows Lasting Tissue Healing In Patients With Inflamed Esophagus - Sahm
Why Eupraxia Pharmaceuticals Inc. stock could benefit from AI revolution2025 Earnings Impact & AI Forecasted Entry/Exit Points - ulpravda.ru
What insider trading reveals about Eupraxia Pharmaceuticals Inc. stockWeekly Investment Summary & Smart Allocation Stock Tips - ulpravda.ru
Is Eupraxia Pharmaceuticals Inc. stock a buy on dips2025 Price Action Summary & Stepwise Trade Signal Guides - ulpravda.ru
Will Eupraxia Pharmaceuticals Inc. stock continue dividend increases2025 Big Picture & Consistent Growth Stock Picks - ulpravda.ru
How Eupraxia Pharmaceuticals Inc. stock reacts to inflationary pressuresJuly 2025 Trade Ideas & Capital Efficiency Focused Strategies - ulpravda.ru
(EPRX.WT.A) Investment Analysis and Advice - Stock Traders Daily
Eupraxia Pharmaceuticals Reports Positive Tissue Health Data from its Ongoing RESOLVE Trial in Eosinophilic Esophagitis Demonstrating Near-Complete Improvement on Biopsy - Investing News Network
Eupraxia Pharmaceuticals Announces Positive Tissue Health Data From Its Ongoing RESOLVE Trial - Nasdaq
Eupraxia Posts Strong Mid-Stage Data for Once-Yearly EoE Therapy EP-104GI - TipRanks
Eupraxia Pharmaceuticals reports positive tissue health data from its ongoing resolve trial - MarketScreener
Eupraxia Pharmaceuticals Brief: Reporting "Positive" Tissue Health Data from its Ongoing RESOLVE Trial in Eosinophilic Esophagitis Demonstrating Near-Complete Improvement on Biopsy - MarketScreener
Once-yearly EoE treatment shows near-healed esophagus tissue, no serious harms - Stock Titan
(EPRX) Daily Stock Insights (EPRX:CA) - Stock Traders Daily
Eupraxia Pharmaceuticals (OTCMKTS:EPRXF) Trading Up 0.3% – Here’s What Happened - Defense World
(EPRX.WT.A) Advanced Equity Analysis - Stock Traders Daily
(EPRX) Technical Data (EPRX:CA) - Stock Traders Daily
(EPRX.WT.A) Stock Trading Blueprint - Stock Traders Daily
(EPRX) Comprehensive Trading Strategy Report (EPRX:CA) - Stock Traders Daily
(EPRX.WT.A) Daily Stock Insights - Stock Traders Daily
Uncover the Best-Performing Canadian Biotech Stocks of 2025 - Investing News Network
Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX) Short Interest Up 30.1% in December - MarketBeat
Trading (EPRX) With Integrated Risk Controls (EPRX:CA) - Stock Traders Daily
How the (EPRX.WT.A) price action is used to our Advantage - Stock Traders Daily
(EPRX) Equity Market Report (EPRX:CA) - Stock Traders Daily
562,500 Non-Voting Class B Shares of Eupraxia Pharmaceuticals Inc. are subject to a Lock-Up Agreement Ending on 22-DEC-2025. - MarketScreener
Will Eupraxia Pharmaceuticals Inc. stock reach Wall Street targetsEntry Point & Community Verified Swing Trade Signals - Улправда
(EPRX) Advanced Trading Insights (EPRX:CA) - Stock Traders Daily
Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX) Given Consensus Rating of “Buy” by Brokerages - Defense World
Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX) Given Consensus Rating of "Buy" by Brokerages - MarketBeat
Why Eupraxia Pharmaceuticals Inc. stock is a must watch in 2025Quarterly Trade Report & Long-Term Safe Return Strategies - Улправда
Moving Averages: Why Eupraxia Pharmaceuticals Inc. stock is a must watch in 2025July 2025 News Drivers & Momentum Based Trading Ideas - Улправда
Can Eupraxia Pharmaceuticals Inc. stock beat analyst upgradesMarket Movement Recap & Free Weekly Chart Analysis and Trade Guides - Улправда
Stock Report: Will Eupraxia Pharmaceuticals Inc. stock deliver better than expected guidanceJuly 2025 Price Swings & Long-Term Safe Return Strategies - Улправда
Why Eupraxia Pharmaceuticals Inc. stock could see breakout soonDay Trade & Risk Controlled Stock Pick Alerts - Улправда
Aug Decliners: Why Eupraxia Pharmaceuticals Inc. stock could benefit from AI revolution2025 Historical Comparison & Daily Chart Pattern Signals - Улправда
Aug Final Week: How Eupraxia Pharmaceuticals Inc. stock valuations compare to rivalsTrend Reversal & High Accuracy Investment Entry Signals - Улправда
How geopolitical risks impact Eupraxia Pharmaceuticals Inc. (X43) stockWeekly Trade Review & Risk Controlled Swing Alerts - Улправда
Market Review: Why Eupraxia Pharmaceuticals Inc. stock could benefit from AI revolutionTrade Entry Summary & Growth Oriented Trade Recommendations - Улправда
(EPRX.WT.A) Stock Evaluation Report - Stock Traders Daily
Why Eupraxia Pharmaceuticals Inc. stock remains a top recommendationProduct Launch & Intraday High Probability Alerts - DonanımHaber
Will Eupraxia Pharmaceuticals Inc. stock deliver better than expected guidance2025 Risk Factors & Daily Market Momentum Tracking - Улправда
Bearish Setup: Why Eupraxia Pharmaceuticals Inc. stock could see breakout soon2025 Institutional Moves & Low Risk Entry Point Tips - Улправда
(EPRX.WT.A) Strategic Equity Report - Stock Traders Daily
How to Take Advantage of moves in (EPRX) (EPRX:CA) - news.stocktradersdaily.com
FY2025 Earnings Estimate for EPRX Issued By Lifesci Capital - MarketBeat
(EPRX.WT.A) Risk-Controlled Trading Report - news.stocktradersdaily.com
Finanzdaten der Eupraxia Pharmaceuticals Inc-Aktie (EPRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):